Joseph Markowitz
Impact in
- Immunology top 5%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Melanoma and MAPK Pathways 19
- S100 Proteins and Annexins 8
- Oncology 44
- Cancer Immunotherapy and Biomarkers 19
- CAR-T cell therapy research 15
- Cutaneous Melanoma Detection and Management 10
- Co-authors
- William E. Carson (22 shared papers)Robert Wesolowski (4 shared papers)David J. Weber (7 shared papers)John A. Swets (6 shared papers)Taylor Brooks (6 shared papers)Tracey L. Papenfuss (2 shared papers)France Carrier (3 shared papers)Hayyoung Lee (1 shared paper)
- Journals
- Journal of Clinical Oncology (19 papers)Annals of Oncology (6 papers)Cancer Research (5 papers)The Journal of the Acoustical Society of America (4 papers)Journal for ImmunoTherapy of Cancer (4 papers)
- Partner nations
- United StatesAustraliaIndia
In The Last Decade
Joseph Markowitz
98 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 131
- Immunology 834
- Oncology 759
- Cancer Research 258
- Molecular Biology 1.0k
- Hepatology 65
Countries citing papers authored by Joseph Markowitz
This map shows the geographic impact of Joseph Markowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Markowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Markowitz more than expected).
Fields of papers citing papers by Joseph Markowitz
This network shows the impact of papers produced by Joseph Markowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Markowitz. The network helps show where Joseph Markowitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Joseph Markowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 247 | |
| 2 | 2013 | 148 | |
| 3 | 2012 | 145 | |
| 4 | 2004 | 118 | |
| 5 | 2014 | 104 | |
| 6 | 2002 | 99 | |
| 7 | 1967 | 96 | |
| 8 | 2009 | 93 | |
| 9 | 2004 | 85 | |
| 10 | 2005 | 84 | |
| 11 | 2017 | 81 | |
| 12 | 2018 | 79 | |
| 13 | 2017 | 59 | |
| 14 | 2017 | 57 | |
| 15 | 2005 | 55 | |
| 16 | 2017 | 48 | |
| 17 | 2023 | 41 | |
| 18 | 2022 | 34 | |
| 19 | 2021 | 33 | |
| 20 | 2005 | 30 |
About Joseph Markowitz
Joseph Markowitz is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Biotechnology, having authored 107 papers that have together received 2.3k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (19 papers), Cancer Immunotherapy and Biomarkers (19 papers), Immunotherapy and Immune Responses (18 papers), CAR-T cell therapy research (15 papers), Immune cells in cancer (11 papers), Cutaneous Melanoma Detection and Management (10 papers), S100 Proteins and Annexins (8 papers) and Cancer Research and Treatments (6 papers). The work is most often cited by research in Immunology (834 citations), Oncology (759 citations), Cancer Research (258 citations), Molecular Biology (1.0k citations) and Hepatology (65 citations). Joseph Markowitz has collaborated with scholars based in United States, Australia and India. Frequent co-authors include William E. Carson, Robert Wesolowski, David J. Weber, John A. Swets, Taylor Brooks, Tracey L. Papenfuss, France Carrier, Hayyoung Lee, Jie‐Oh Lee and Paul T. Wilder. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, The Journal of the Acoustical Society of America and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.